MWM @MWM76 I’ve been there done that. Humanigen’s drug worked as well, but not enough statistically. Now you think in the most difficult of diseases Remi is going to crack the code on Alzheimer’s, like I’ve said before, good luck with that… 10:20 AM · Jul 2, 2024 · 22 Views
Jay Booth @booth37337 · 9m WHAT THIS STUDY ADDS. Participants with baseline CRP <150 mg/L represented 78% of the LIVE-AIR study population and demonstrated the greatest improvement in SWOV with lenzilumab, through day 28 (HR: 2.54; 95% CI 1.46 to 4.41; p=0.0009). From thorax.bmj.com
I’ve been there done that. Humanigen’s drug worked as well, but not enough statistically. Now you think in the most difficult of diseases Remi is going to crack the code on Alzheimer’s, like I’ve said before, good luck with that…
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.